Deprescribing: barriers and enablers

Kristen Anderson
Community pharmacists can play a strong role in identifying patients who would benefit from a review of their medicines with a view to deprescribing, says one expert. Kristen Anderson from the University of Queensland presented a poster at the National Medicines Symposium on “Negotiating ‘unmeasurable harms and benefits’ – General practitioners’ and consultant pharmacists’ barriers

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Harm minimisation efforts pay big dividends
Next Forum: pharmacy administers over 2,000 vaccinations